ArticleRespiratory research2026
Myeloid-specific Becn1 deficiency elicits spontaneous pulmonary injury and exacerbates acute lung injury.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAcute lung injury (ALI) and its severe phenotype, acute respiratory distress syndrome (ARDS), represent devastating and highly lethal respiratory disorders. Hallmarked by unrestrained pulmonary inflammation predominantly driven by myeloid cells, these conditions ultimately culminate in profound disruption of the alveolar-capillary barrier. The reciprocal crosstalk between autophagy and inflammation and its molecular underpinnings in ALI pathogenesis remain incompletely defined.
methodsThe role of myeloid Becn1 in maintaining pulmonary homeostasis and modulating susceptibility to lipopolysaccharide (LPS)-induced ALI was defined, and the potential link between intestinal barrier integrity, gut microbiota, and ALI severity was further interrogated. The expression of BECN1 in bronchoalveolar lavage fluid (BALF) cells from patients with ARDS and in lung tissues of mice with LPS-induced ALI was detected by western blot and immunofluorescence respectively. Myeloid cell-specific Becn1 conditional knockout (cKO) mice were generated. Parallel analyses were performed in both steady-state and LPS-challenged mice, including quantitative lung histopathological analysis, inflammatory cytokine profiling of BALF, bulk RNA sequencing of lung tissue, histological assessment of intestinal architecture and intestinal tight junction integrity, and 16S rRNA gene sequencing of fecal microbiota.
resultsMyeloid Becn1 deficiency alone was sufficient to disrupt pulmonary homeostasis, leading to spontaneous lung injury characterized by increased alveolar-capillary permeability, inflammatory cell infiltration, and aberrant activation of immune-inflammatory pathways. When challenged with LPS, these pre-existing inflammatory priming effects translated to exacerbated pulmonary pathology and exaggerated cytokine storm. Beyond the lung, Becn1 cKO mice developed spontaneous intestinal barrier dysfunction and gut microbiota dysbiosis at steady state, including blunted intestinal villi, reduced goblet cells, impaired tight junction integrity, increased mast cell infiltration, and a characteristic microbial shift with depleted Actinobacteria and expanded Alistipes. All these intestinal and microbial perturbations were likely further amplified by LPS challenge, consistent with a potential association between intestinal-microbial dysregulation and exacerbated pulmonary injury.
conclusionsMyeloid Becn1 governs pulmonary-intestinal immune homeostasis, and its deficiency drives spontaneous lung injury, hyperinflammation, impaired gut-lung crosstalk, and exacerbated acute lung injury, establishing myeloid Becn1 as a critical determinant of acute lung injury severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.